未知股票 NVRO 深 滬
已收盤 04-02 16:00:00 美东时间
5.84
0.000
0.00%
華盛通- 最 高--
- 今 開--
- 成交量 0股
- 最 低 --
- 昨 收 5.84
- 總市值 2.24亿
- 52周最高 --
- 市盈率 靜 --
- 換手率 0.00%
- 52周最低 --
- 委 比 0.00%
- 總股本 3837.20万
- 歷史最高 --
- 量 比 0
- 振 幅 0.00%
- 歷史最低 --
- 每 手 1
- 風險率 2.14%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多EnviroGold Global Advances NVRO Process for Rare Earth Recovery
EnviroGold Global Limited ( ($TSE:NVRO) ) has issued an update. EnviroGold Glob...
2025-04-15 00:05
Nevro Corp Completes Merger and Delists from NYSE
Nevro Corp ( ($NVRO) ) has provided an announcement. On April 3, 2025, Nevro Co...
2025-04-03 21:19
EnviroGold Global Secures Oversubscribed Funding, Boosting Growth Initiatives
EnviroGold Global Limited ( ($TSE:NVRO) ) has shared an announcement. EnviroGol...
2025-03-04 01:13
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates AMPS, PLYA, NVRO on Behalf of Shareholders
NEW YORK, Feb. 25, 2025 /PRNewswire/ -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws and/or...
2025-02-25 15:26
On Stand-Alone Basis, Globus Medical Reaffirms 2025 Revenue Guidance Of $2.66B - $2.69B (Est $2.671B) And Adj EPS Of $3.40 - $3.50 (Est $3.43)
Following the consummation of the Nevro, Inc. acquisition, which it expects to close in the late second quarter of 2025, Globus Medical anticipates 2025 net sales of $2.80 billion to $2.90 billion and Adj EPS of $3.10 to
2025-02-21 05:29
Baxter Q4 Earnings Beat Expectations, Issues Strong 2025 Outlook
Baxter International exceeded Q4 earnings and revenue estimates, with strong pharmaceutical sales. The company issued a mixed 2025 outlook amid cost pressures.
2025-02-21 01:41
Analyst Cautiously Optimistic On DexCom As Competitive Pressures Loom
DexCom reported Q4 revenue of $1.11 billion, surpassing estimates. The company reaffirmed its 2025 outlook while analysts highlighted long-term growth potential.
2025-02-15 04:04
Analysts Offer Insights on Healthcare Companies: Nevro Corp (NVRO) and Ansell (OtherANSLF)
Analysts have been eager to weigh in on the Healthcare sector with new ratings ...
2025-02-12 09:51
Elliott Management's Activist Campaigns: The Special Situations Report
Asif Suria from Inside Arbitrage shares his expert insights on Elliott Management's activist campaigns and other special situations.
2025-02-11 07:10
美股大行评级 | 潜在涨幅52%！微策略获机构升目标价至500美元，维持"买入"评级
<span> <meta content="no-referrer" name="referrer"></span><p>https://static-hk.hstong.com/public/forum-v2/status/icon/50267976/originalpic/1094906435582308353.png</p><span style="color:#999999;">编者按：每日追踪华尔街最新评级与目标价，挖掘潜力股投资机会。</span><blockquote> <p><span style="color:#fa1432;"><strong>今日重点评级关注</strong></span></p></blockquote><p>• 瑞杰金融：维持Viking Therapeutics(VKTX)"强烈买入"评级，目标价从122美元升至125美元</p> <p>• Canaccord Genuity：维持HIVE Digital Technologie
2025-02-08 09:32
